Cite
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study
MLA
Davide Olivari, et al. “Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study.” Stroke, vol. 52, no. 4, Feb. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....99b4050e50044ac7bad94e882b0d2eda&authtype=sso&custid=ns315887.
APA
Davide Olivari, Elisabetta Dejana, Maria Grazia Lampugnani, Francesca Fumagalli, Peetra U. Magnusson, Charlotte Rorsman, Dinesh Fernando, Monica Corada, Maximiliano Arce, Galina V. Beznoussenko, Maria Ascención Globisch, Lei Liu Conze, Geoffrey Daniel, Alexander A. Mironov, Veronica Sundell, Caroline Öhman Mägi, Matteo Malinverno, Gry Hulsart Billström, Fabrizio Orsenigo, … Joppe Oldenburg. (2021). Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study. Stroke, 52(4).
Chicago
Davide Olivari, Elisabetta Dejana, Maria Grazia Lampugnani, Francesca Fumagalli, Peetra U. Magnusson, Charlotte Rorsman, Dinesh Fernando, et al. 2021. “Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations: A Preclinical Study.” Stroke 52 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....99b4050e50044ac7bad94e882b0d2eda&authtype=sso&custid=ns315887.